Making decisions session at #EULAR2021 @DanielAletaha When designing for a superiority trial you cannot conclude on non-inferiority. Trials in JAK-i show more or less similar efficacy results to #TNFi Some JAK-i might work better for specific patient #pain #EULAR2021 @RheumNow https://t.co/Bo81nwBFbZ